NCT05342805

Brief Summary

Currently, both the subtotal stomach and narrow gastric tube approaches are widely used for esophagogastric anastomosis after esophagectomy. Some stud- ies have concluded that the subtotal gastric conduit is superior to the wide gastric-tube approach, as it provides better protection of the submucosal vessels and can slightly increase gastric capacity. Furthermore, blood perfusion significantly decreases after tubular gastric surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

May 3, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

April 28, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

April 8, 2022

Last Update Submit

April 27, 2022

Conditions

Keywords

subtotal stomachnarrow gastric tubeanastomosis

Outcome Measures

Primary Outcomes (8)

  • Early complications (30-day complications): rate of anastomotic leakage

    Comparison of the rate of anastomotic leakage. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early complications (30-day complications): rate of anastomotic stricture

    Comparison of the rate of anastomotic stricture. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early complications (30-day complications): rate of bleeding

    Comparison of the rate of bleeding. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early complications (30-day complications): rate of pneumonia

    Comparison of the rate of pneumonia. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early complications (30-day complications): rate of mortality.

    Comparison of the rate of anastomotic leakage. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early complications (30-day complications): rate of reoperation.

    Comparison of the rate of reoperation. All complications will be classified according to the Clavien-Dindo classification.

    30 days after surgery

  • Early outcomes (30-day post operative): length of hospital stay.

    Comparison of the length of hospital stay.

    30 days after surgery

  • Early outcomes (30-day post operative): day of oral intake.

    Comparison of the day of oral intake.

    30 days after surgery

Secondary Outcomes (13)

  • Postoperative nutritional status: body weight

    6, 12 months and 1 year after surgery

  • Postoperative nutritional status: serum total protein

    6, 12 months and 1 year after surgery

  • Postoperative nutritional status: albumin level

    6, 12 months and 1 year after surgery

  • Postoperative nutritional status: hemoglobin

    6, 12 months and 1 year after surgery

  • Reflux esophagitis

    6, 12 months and 1 year after surgery

  • +8 more secondary outcomes

Study Arms (2)

Subtotal stomach

EXPERIMENTAL

The vessels at the anastomosis of right and left gastric arteries were separated, then the proximal haft of lesser curvature and cardia was resected using linear staplers.

Procedure: Narrow gastric tube

Narrow gastric tube

ACTIVE COMPARATOR

At the lesser curvature, the resection began at the point that was 5-cm from the pyloric, toward to the greater curvature, then the stomach was divided along 3 cm from the greater curvature using linear stapler.

Procedure: Narrow gastric tube

Interventions

At the lesser curvature, the resection began at the point that was 5-cm from the pyloric, toward to the greater curvature, then the stomach was divided along 3 cm from the greater curvature using linear stapler

Narrow gastric tubeSubtotal stomach

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pathologic finding by esophageal endoscopy: confirmed esophageal cancer.
  • Indication for esophagectomy
  • Age: 18 - 80 year old
  • Tumor located at the middle or lower third of the esophagus
  • ASA score: ≤ 3
  • Informed consent patients (explanation about our clinical trials is provided to the patients or patrons, if patient is not available)

You may not qualify if:

  • Concurrent cancer or patient who was treated due to other cancer before the patient was diagnosed esophageal cancer
  • Pregnant patient
  • Using colon or intesinal conduit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Ho Chi Minh City

Ho Chi Minh City, 700000, Vietnam

Location

MeSH Terms

Conditions

Esophageal Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases

Study Officials

  • Long D Vo, MD, PhD

    University Medical Center, HCMC, VN

    STUDY DIRECTOR

Central Study Contacts

Long D Vo, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2022

First Posted

April 25, 2022

Study Start

May 3, 2022

Primary Completion

April 15, 2024

Study Completion

August 30, 2024

Last Updated

April 28, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations